Literature DB >> 7030523

Enzyme immunoassay of disopyramide in serum.

B E Pape.   

Abstract

Disopyramide, an antiarrhythmic drug, was quantitated in serum by a commercially supplied enzyme immunoassay procedure. Replicate analyses of serum controls resulted in a within-assay coefficient of variation of less than or equal to 5% and a between-assay coefficient of variation of less than or equal to 7%. Regression analysis of 105 serum samples analyzed by this technique (y) and by gas chromatography (x) gave the equation y = 0.99x + 0.04 (r = 0.97). Clinical evaluation of the results indicates the enzyme immunoassay technique to be highly specific and sensitive for disopyramide. The selectivity of the assay vs other drugs has been determined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030523

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Pharmacokinetic-pharmacodynamic analysis of unbound disopyramide directly measured in serial plasma samples in man.

Authors:  M Thibonnier; N H Holford; R A Upton; C D Blume; R L Williams
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

2.  Disopyramide pharmacokinetics and metabolism: effect of inducers.

Authors:  R P Kapil; J E Axelson; I L Mansfield; D J Edwards; B McErlane; M A Mason; D Lalka; C R Kerr
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

3.  The impact of neglecting nonlinear plasma-protein binding on disopyramide bioavailability studies.

Authors:  R A Upton; R L Williams
Journal:  J Pharmacokinet Biopharm       Date:  1986-08

4.  In vivo interaction of the enantiomers of disopyramide in human subjects.

Authors:  K M Giacomini; W L Nelson; R A Pershe; L Valdivieso; K Turner-Tamiyasu; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1986-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.